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The mitochondrion plays a central role in the control of apoptosis
(Kroemer et al, 1997; Green and Reed, 1998) by releasing the
apoptogenic proteins apoptosis-inducing factor (AIF) (Susin et al,
1999) and cytochrome c into the cytosol. The released proteins
activate pathways essential for carrying out the morphological and
biochemical changes initiated by a variety of death stimuli (Gross
et al, 1999). For example, cytochrome c, which normally resides
between the mitochondrial outer and inner membranes and serves
as a diffusible electron carrier in the intermembrane space (Cortese
and Hackenbrock, 1993), has been demonstrated to be a co-
activator of caspase-9, which in turn activates caspase-3 (Liu et al,
1996; Kluck et al, 1997; Yang et al, 1997). The active caspase-3
then activates CAD (caspase-activated DNase) through proteolytic
inactivation of its bound inhibitor ICAD (Liu et al, 1997; Enari 
et al, 1998). Active CAD translocates from the cytosol into 
the nucleus to initiate chromatin condensation and DNA 
fragmentation. 
Although the mechanism by which the apoptosis-inducing
proteins are released from mitochondria remains unclear, the
release is regulated by members of the Bcl-2 family of proteins in
that anti-apoptotic members, such as Bcl-2 and Bcl-xL, suppress,
and pro-apoptotic members, such as Bax and Bak, promote the
release (Reed et al, 1998; Gross et al, 1999). The Bcl-2 family
proteins either reside on the mitochondrial membrane or are translo-
cated there during apoptosis. Several models have been proposed
for the release of cytochrome c from mitochondria (Martinou et al,
2000). One model proposes that the release depends on the mito-
chondrial permeability transition (PT) (Susin et al, 1998), which
represents an abrupt increase in the permeability of the mito-
chondrial inner membrane to molecules of less than 1500 Da
(Zoratti and Szabo, 1995; Lemasters et al, 1998). It is believed that
PT is a consequence of the opening of protein channels or pores in
the membrane, called permeability transition pores (PTP) (Kroemer
et al, 1997; Green and Reed, 1998). The ill-defined PTP is located
at sites of contact of the inner and outer membranes and consists of
several protein components, including the adenine nucleotide
translocator (ANT) and the voltage-dependent anion channel
(VDAC). According to this model, the opening of the PTP would
lead to the influx of water and solutes into the matrix, causing
swelling of the mitochondria, and eventually the rupture of the outer
membrane (Vander Heiden et al, 1997). The model predicts that
opening of the PTP would result in dissipation of the electrochem-
ical gradient across the inner membrane (Dym), resulting in mito-
chondrial depolarization and disruption of respiration. 
However, evidence that runs contrary to this model has been
reported. First, time-course studies have demonstrated that release
of cytochrome c can precede membrane depolarization (Yang et al,
1997; Bossy-Wetzel et al, 1998). And second, the release of
cytochrome  c can occur in the absence of mitochondrial depolar-
ization (Kluck et al, 1997; Eskes et al, 1998; Finucane et al, 1999a,
1999b; Goldstein et al, 2000). Alternative models (Martinou et al,
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pores or channels in the outer membrane large enough for the
passage of cytochrome c. Pro-apoptotic Bcl-2 family proteins,
such as Bax, may participate in the channel formation. 
In this study, we investigated the role of the mitochondrial PT in
cytochrome  c release and apoptosis induced by photodynamic
therapy (PDT). PDT is a treatment for cancer and other abnormal
tissue that employs a photosensitizer and visible light to produce
singlet oxygen and other reactive oxygen species (Weishaupt et al,
1976), which cause an oxidative stress in cells and membrane
damage (Moan and Berg, 1992) and eventually leads to cell death
and tumour ablation (reviewed in Dougherty, 1993; Dougherty
et al, 1998). PDT with photosensitizers that localize in the mito-
chondria induces rapid apoptosis (Agarwal et al, 1991; Dougherty,
1993; He et al, 1994; Luo et al, 1996; Luo and Kessel, 1997;
Dougherty et al, 1998; Oleinick and Evans, 1998), probably
because the photochemical damage directly targets mitochondria
(Kessel and Luo, 1998) to elicit the rapid release of cytochrome c
that initiates caspase-9 activation, subsequent steps in the caspase
cascade, and morphological apoptosis (Kroemer et al, 1997;
Granville et al, 1998, 1999; Kessel and Luo, 1999; Varnes et al,
1999). Data in the present study show that mitochondrial depolari-
zation caused by PDT is dose dependent, and PDT-induced
cytochrome  c release and apoptosis can occur in the absence of
major loss of the Dym. 
MATERIALS AND METHODS 
Photosensitizer 
The silicon phthalocyanine Pc 4[HOSiPcOSi(CH3)2(CH2)3(CH3)2]
was supplied by Drs Ying-syi Li and Malcolm E Kenney of the
Department of Chemistry, CWRU, and used as a 0.5 mM stock
solution in dimethyl formamide. For experiments, Pc 4 was added
to the medium of the cell cultures to a final concentration of
300 nM. 
Cell culture and photodynamic treatment 
Mouse lymphoma L5178Y-R (LY-R) cells were cultured in
Fisher’s medium supplemented with 5 mM glutamine and 10%
heat-inactivated horse serum in a humidified atmosphere at 37˚C
with 5% CO2. Pc 4 was added to the cultures growing in T-25
flasks to a final concentration in the medium of 300 nM, 16–18 h
before light exposure. Cells in the original culture flasks were
irradiated using a light-emitting diode (LED) array (EFOS, Missis-
sauga, Ontario, Canada, lmax 670–675 nm) followed by incubation in
the dark for various periods of time before harvest. 
Nuclear staining assay for apoptotic cells 
Apoptotic cells were identified by fluorescence microscopy from
their characteristic nuclear features of chromatin condensation and
fragmentation after staining the cells with 1–5 mg ml–1 Hoechst
33342. At least 200 cells were counted from each sample, and the
yield of apoptotic cells was expressed as the percentage of the total
population. 
Fluorescence immunocytochemistry 
Cells were washed in sucrose buffer (0.25 M sucrose, 10 mM
Tris-HCl, 3 mM MgCl2, pH 7.4) and fixed in methanol at –20˚C
for 10 min. After rinsing twice with PBS, the cells were allowed to
attach to gelatin-coated coverslips, which were then air-dried. The
coverslips containing attached cells were incubated in IFA buffer
(PBS containing 1% bovine serum albumin, 0.1% Tween 20) for
10 min and then in IFA containing mouse anti-cytochrome c anti-
body (1:100 dilution, clone 6H2.B4, PharMingen) for 1 h to
overnight at 4˚C. After rinsing with IFA buffer to remove excess
unbound antibody, the coverslips were incubated for at least 1 h at
4˚C in IFA containing the second antibody, which was anti-mouse
IgG conjugated to Texas red (1:100 dilution, Vector Laboratories).
Following thorough rinsing, the samples were stained with
0.5 mg/ml Hoechst 33342 and examined with a Leitz fluorescence
microscope or a Zeiss 410 confocal microscope. 
Measurement of mitochondrial membrane potential 
Changes in Dym were monitored by the uptake of JC-1 or
rhodamine-123 (Rh-123). JC-1 (5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢ -
tetraethylbenzimidazolylcarbocyanine iodide) was supplied by
Molecular Probes and dissolved in DMSO to produce a 1 mg ml–1
stock solution. Rh-123 was supplied by Eastman Kodak and
dissolved in DMSO to produce a 1 mM stock solution. Cells were
incubated at 37˚C for consecutive 15-min periods starting immedi-
ately after light exposure until 45–60 min after PDT in culture
medium containing 10 mgm l –1 JC-1 or 1 mM Rh-123. Samples
labelled with JC-1 were either unwashed or washed once with
HBSS before being analysed with an EPICS ESP flow cytometer
(Coulter Corp) in the Flow Cytometry Facility of the Case Western
Reserve University/Ireland Comprehensive Cancer Center with
settings of FL1 at 530 nm and FL2 at 585 nm. A portion of the
sample was also stained with Hoechst 33342 and examined with a
fluorescence microscope. JC-1 is a lipophilic cationic dye which
accumulates and forms aggregates in normal mitochondria with a
high negative membrane potential, in which condition it emits a
red-orange fluorescence, detected at 585 nm, whereas in mito-
chondria with low membrane potential it forms monomers in the
cytosol that emit a green fluorescence, detected at 530 nm
(Cossarizza et al, 1993). 
For fluorescence microscopy, labelled samples were washed
once with PBS and examined for red-orange fluorescence (580
nm). Despite some variation in the level of Rh123 or JC-1 fluores-
cence intensity among control cells, all cells displayed bright
perinuclear and punctate fluorescence, an indication of the accu-
mulation of the dye in mitochondria. In contrast, cells pre-treated
with the uncoupler of oxidative phosphorylation, CCCP (carbonyl
cyanide  m-chlorophenylhydrazone), which abolishes the mito-
chondrial membrane potential, prior to dye labelling displayed
very weak fluorescence with little or no evidence of a bright punc-
tate staining pattern. This indicates that mitochondrial depolariza-
tion can be readily demonstrated by these dyes in LY-R cells. In
the determination of the percentage of cells that had lost ∆ Ym
following PDT, only cells with very low fluorescence were scored.
At least 200 cells were scored for each sample. 
Measurement of caspase activity 
Samples were prepared and assayed for caspase-3-like activity as
described (Varnes et al, 1999). Briefly, samples containing 50 mg
protein was incubated in 60 ml of reaction buffer (25 mM HEPES,
10% sucrose, 0.1% Chaps, 1 mM EGTA, 1 mM EDTA, 5 mM
dithiothreitol, 1 mM phenylmethylsulphonyl fluoride, 100 mM
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AMC (BIOMOL) for 1 h at 37˚C. The released fluorescence
was measured in a Perkin-Elmer LS50 fluorometer (lex 380 nm;
lem 460 nm). 
RESULTS 
We have previously demonstrated that the extent and timing of
induction of apoptosis by Pc 4-PDT in mouse lymphoma LY-R
cells was dose dependent (He et al, 1998). In order to test a
possible correlation between the loss of ∆ Ym and cytochrome c
release and apoptosis, 3 doses of PDT were chosen for this study;
LY-R cells were treated with 300 nM Pc 4 and irradiated with
either 60, 90 or 120 mJ/cm2 red light. As determined by clono-
genic assay, PDT with the lowest dose results in killing of 99% of
the cells (Chiu et al, 2001). Figure 1 shows that all 3 PDT doses
caused greater than 80% of the cells to undergo nuclear apoptosis
within 1 h. An even higher incidence of apoptotic figures (92.3 ±
0.6%) was observed 2 h after these 3 doses of Pc 
4-PDT, and extensive degradation of DNA to oligonucleosome-
size fragments was detected at this time (not shown). Since
caspase-3 is the key ‘executioner’ of apoptosis and our previous
studies have shown its activity elevated markedly after PDT with
Pc 4 in LY-R cells (He et al, 1998; Varnes et al, 1999), the activa-
tion of this caspase was investigated as a function of the same PDT
doses. As shown in Figure 2, DEVDase activity rose rapidly
following each dose of PDT, reaching a maximum level, 20–30-
fold higher than in untreated cells, by 30–60 min after PDT. The
rate of activation of caspase-3 was PDT dose-dependent, however,
with the most and least rapid activation of the caspase occurring in
response to the highest and lowest dose of PDT, respectively. 
The effect of PDT on the loss of mitochondrial membrane
potential (∆ Ym) was monitored by the uptake of JC-1, a cationic,
lipophilic fluorescent dye that accumulates in normal mito-
chondria with a negative ∆ Ym, resulting in an intramitochondrial
concentration that is 2–3 logs higher than in the cytosol. Under this
condition, JC-1 forms aggregates that emit red fluorescence. In
contrast, disruption of ∆ Ym results in a much reduced uptake of
JC-1. This dye thus provides a very sensitive method to measure
changes in ∆ Ym. To monitor the effect of the chosen doses of Pc 
4-PDT on mitochondrial ∆ Ym, cells were allowed to take up JC-1
during consecutive 15-min periods from immediately following
PDT until 60 min later at which time the treated cells were in
PDT apoptosis without mitochondrial depolarization 1101
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Figure 1 Levels of apoptosis induced by various doses of PDT. LY-R cells
were exposed to 300 nM Pc 4 and 0, 60, 90 or 120 mJ/cm2 of red light
delivered by an LED array. One hour after treatment, cells were collected and
stained with Hoechst 33342 and examined by fluorescence microscopy.
Apoptotic cells were identified by condensation and fragmentation of their
nuclei. At least 200 cells were scored for each sample 
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Figure 2 Elevation of caspase-3-like protease activity in LY-R cells after
various doses of PDT. LY-R cells were treated as for Figure 1 and at the
times indicated, cells were collected and lysed. 50 mg of lysate protein were
incubated with DEVD.AMC at 37˚C for 1 h. The fluorescence intensity of
released AMC was measured. Data represent the mean ± SD of at least 3
independent experiments nuclear apoptosis. The labelled cells were analysed either by flow
cytometry (Figure 3) or by fluorescence microscopy (Figure 4). 
The flow cytometric analysis of JC-1 uptake following each of
the 3 doses of PDT shows clearly that the observed effect of PDT
1102 S-M Chiu and NL Oleinick
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Figure 3 Time-course of changes in mitochondrial membrane potential after PDT, as determined by the uptake of JC-1. LY-R cells were treated as described
for Figure 1. At consecutive 15-min intervals thereafter, cells were collected and incubated in medium containing JC-1 for 15 min. The labelled cells were then
analysed by flow cytometry to measure the uptake of JC-1, an indicator of mitochondrial membrane potential (Dym). In the histograms of cells stained with JC-1,
the labels ‘Aggregates’ for the ordinate and ‘Monomers’ for the abscissa are derived from the fluorescence readings in the 2 channels, FL2 (585 nm) and FL1
(530 nm), of the flow cytometer, respectively. Thus cells with high red fluorescence (high Dym) are found in the upper right quadrant (box C); those with low Dym
are in the lower right quadrant (box D). The percentage in parentheses in the lower left of each profile represents the percentage of the total cells with low
fluorescence intensity (box D of each histogram) 
Control 0-15 post-PDT
(min)
45-60
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Figure 4 Fluorescence micrographs of LY-R cells stained with JC-1 (red) and Hoechst 33342 (green). LY-R cells receiving 300 nM Pc 4 and either 0 or 90
mJ/cm2 red light were labelled with JC-1 as for Figure 3, stained with Hoechst 33342, and visualized by confocal microscopy on ∆ Ym is dependent on both the dose and the post-treatment time
(Figure 3). The highest dose of PDT (300 nM Pc 4 + 120 mJ/cm2)
caused a marked reduction of JC-1 uptake immediately after PDT
in >70% of the cells. Thereafter, the fraction of cells with low ∆ Ym
increased gradually to about 90% during the 45–60 min time
period. In contrast, there was little or no immediate change in ∆ Ym
in cells receiving either of the lower doses of Pc 4-PDT. However,
at later times, up to 13 and 34% of the cells revealed low ∆ Ym after
exposure to 60 and 90 mJ/cm2, respectively. A portion of the JC-1
labelled cells was also stained with Hoechst 33342 and examined
by confocal microscopy. An example of cells treated with 300 nM
Pc 4 and 90 mJ/cm2 of red light is displayed in Figure 4. In control
untreated cells, JC-1 fluorescence was found to have a perinuclear
distribution and a punctuate pattern, indicating its location in mito-
chondria (Ankarcrona et al, 1996). A slight reduction in JC-1
fluorescence was observed in cells 15 min after receiving 90
mJ/cm2. However, in these cells the JC-1 fluorescence pattern was
found clustered at 1 or 2 locations within the cytoplasm, in contrast
to the more or less randomly distributed punctuate fluorescence
found for untreated cells. By 60 min after PDT, when the majority
of cells displayed condensed and fragmented chromatin, JC-1 fluo-
rescence was reduced in some of the treated cells. 
To confirm that the change in mitochondrial uptake of a cationic
dye after PDT is not unique to JC-1, another mitochondrial dye
was tested. Rh-123, like JC-1, is a cationic dye that accumulates
into energized mitochondria in response to their negative
membrane potential; this dye has been widely used as a measure of
mitochondrial polarization (Johnson et al, 1981; Emaus et al,
1986). Following exposure of LY-R cells to PDT with 60 or 120
mJ/cm2, cells were labelled with Rh-123 in a manner similar to
that for JC-1, and cells with low ∆ Ym (low Rh-123 uptake) were
observed with a fluorescence microscope and counted. The results
shown in Figure 5 indicate a similar effect on ∆ Ym as that found
using JC-1. For PDT with 60 mJ/cm2, there was no significant
PDT apoptosis without mitochondrial depolarization 1103
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Figure 5 Effect of PDT on the mitochondrial membrane potential of LY-R
cells, as measured by the uptake of Rh-123. LY-R cells treated with 300 nM
Pc 4 were exposed to 0, 60 or 120 mJ/cm2 red light and allowed to take up
Rh-123, as described in Materials and Methods. The data represent the
mean ± SD from 3 experiments 
Control 15 min 60 min
Cyt-C
Nuclei
PDT (300 mM Pc 4+60 mJ/cm2)
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Figure 6 Cytochrome c redistribution visualized by fluorescence microscopy. Immunolocalization of cytochrome c (red) and staining of nuclei with Hoechst
33342 (blue) are shown in untreated cells (left images), and in cells collected at 15 min (middle images) or 60 min (right images) after receiving PDT (300 nM 
Pc 4 + 60 mJ/cm2). Cells were fixed and immunostained with anti-cytochrome c (clone 6H2.B4)increase in the number of cells with low ∆ Ym at early times after
treatment, although nearly 60% of the cells revealed a low ∆ Ym by
45–60 min. For PDT with 120 mJ/cm2, 80% of the cells had lost
∆ Ym at the earliest time period. 
Previously, we and others showed that PDT causes cytochrome
c to be released from the mitochondria into the cytosol prior to
caspase activation (Granville et al, 1998, 1999; Kessel and Luo,
1999; Varnes et al, 1999). However, in those studies, the presence
of cytochrome c in the cytosol was determined by Western blot
analysis following cell homogenization and differential centrifu-
gation. Because of the potential for artifacts due to the physical
stress on organelles during cell fractionation, we employed an
immunocytochemical method to monitor the redistribution of
cytochrome  c from mitochondria to cytosol. Since we used mouse
anti-cytochrome c for this assay, it was important to test that the
LY-R mouse lymphoma cells do not produce sufficient
immunoglobulin IgG to react with the second antibody and inter-
fere with the assay. We found that omission of the first antibody
produced a very clean background in cell preparations, indicating
no appreciable synthesis of IgG by these cells. In contrast, cells
that had reacted with the mouse anti-cytochrome c antibody
before reaction with the second antibody revealed a bright perinu-
clear punctate fluorescence pattern (Figure 6). The perinuclear
location and punctate pattern of cytochrome c staining is consis-
tent with previous reports (Bossy-Wetzel et al, 1998; Rosse et al,
1998; Srinivasan et al, 1998), indicative of the mitochondrial
location of cytochrome c. 
Examples of control and PDT-treated (300 nM Pc 4 and 60
mJ/cm2 red light) LY-R cells examined for cytochrome c distribu-
tion and nuclear morphology are displayed in Figure 6. The
staining of untreated cells for cytochrome c revealed a punctate
pattern, consistent with localization in the mitochondria, and
nuclear morphology was normal. Treated cells maintained the
punctate cytochrome c staining pattern until 10 min post-PDT,
indicating no release of cytochrome c from mitochondria at this
time (not shown). In contrast, by 15 min after PDT the majority of
the treated cells showed a diffuse distribution of red fluorescence,
indicating the release of cytochrome c from mitochondria.
Chromatin condensation started at 45 min and fragmentation at 60
min post-PDT, and apoptotic cells continued to show the diffuse
cytochrome c staining pattern. At later times, the staining of
cytochrome c became very weak (not shown), probably because
the protein leaked out of the cells (Heiskanen et al, 1999). The
majority of the cells that received the higher dose of PDT (300 nM
Pc 4 and 120 mJ/cm2 red light) also released cytochrome c from
mitochondria at 15 min (data not shown). 
DISCUSSION 
The 3 doses of PDT employed in this study induced a similar high
level (80–90%) of cells to undergo apoptosis by 1 h, yet the
responses of the cells in terms of changes in their mitochondrial
membrane potential were strikingly different. The effect of PDT
on ∆ Ym was dose- and time-dependent: whereas the highest dose
of PDT caused >70% of the cells to lose ∆ Ym immediately after
irradiation, virtually all cells receiving lower doses of PDT
showed no significant change in ∆ Ym immediately after PDT,
although 25–60% of the cells showed dissipation of ∆ Ym at later
times coincident with nuclear apoptosis. Thus, with the lower
doses of PDT, the majority of the cells could initiate apoptosis in
the absence of a measurable loss of ∆ Ym. 
According to recent studies (D Godar, personal communica-
tion), JC-1 is susceptible to oxidation by reactive oxygen species,
and the resultant oxidized JC-1 may either lose fluorescence or
show green instead of red fluorescence. Although PDT generates
reactive oxygen species that could oxidize JC-1, our observation
of an immediate loss of ∆ Ym measured with JC-1 following the
highest dose of PDT appears unlikely to be due to a false reading
of oxidized JC-1, because we were able to repeat the observation
with Rh-123, which has also been demonstrated to be a specific
probe for ∆ Ym (Johnson et al, 1981; Emaus et al, 1986). The loss
of ∆ Ym after the highest dose of PDT is likely due to heavy photo-
damage to mitochondrial membranes, since mitochondria are the
most sensitive target of PDT with many currently used photosensi-
tizers (Kessel and Luo, 1998). Loss of ∆ Ym has been demonstrated
in murine leukaemia P388 cells after PDT with the mitochondrion-
localizing photosensitizers PcM (porphycene monomer) and CPO
(9-capronyloxy-tetrakis (methyloxyethyl) porphycene); the response
was observed even when photoirradiation was carried out at 10˚C,
a temperature that would suppress most metabolic processes,
suggesting that direct photodamage to mitochondrial membranes
was responsible (Kessel and Luo, 1999). 
Release of cytochrome c in the absence of dissipation of ∆ Ym has
also been reported for HeLa cells after PDT with Verteporfin
(Carthy et al, 1999). In contrast, a nearly instantaneous depolariza-
tion of mitochondria has been shown following PDT with PcM and
CPO in P388 cells, as described above (Kessel and Luo, 1999), as
well as following treatment of mouse fibroblasts with PDT sensi-
tized by hypericin (Chaloupka et al, 1999). The controversy in these
results could be resolved by careful attention to the delivered dose of
PDT, as demonstrated in this study. However, other factors may also
contibute to the variability in findings, such as differences in the
responses of the cells and/or differences in the photosensitizers
employed and their subcellular binding sites. In a study of the induc-
tion of cytochrome c release from isolated mitochondria by exoge-
nous Bax (Pastorino et al, 1999), both the amount of cytochrome c
released and the extent of mitochondrial swelling and depolarization
were dependent on the concentration of Bax. While a low concen-
tration (125 nM) of Bax produced no detectable mitochondrial
swelling or depolarization, higher concentrations (250–1000 nM)
produced persistent mitochondrial changes. Our results thus confirm
the importance of including a range of doses of the apoptosis-initi-
ating agent in any study of the relationship between membrane
potential, cytochrome c release, and apoptosis. 
Using an immunocytochemical procedure to locate cyto-
chrome c, we have found that the majority of the cytochrome c
was released from mitochondria at 15 min after PDT, regardless of
the dose. The timing of cytochrome c release determined by this
method is similar to the 10–20 min after PDT found previously by
Western blot analysis (Varnes et al, 1999). Except for the highest
dose of PDT (120 mJ/cm2), very little increase in caspase-3
activity was observed at this time (Figure 2). The results confirm
that the release of cytochrome c is coincident with or precedes
the onset of caspase activation. Furthermore, at the time of
cytochrome  c release (15 min post-PDT) only a small fraction of
the cells receiving one of the lower doses of PDT had lost ∆ Ym.
These data are in agreement with the previous conclusion
(Finucane et al, 1999a, 1999b; Goldstein et al, 2000) that dissipa-
tion of ∆ Ym is not required for the release of cytochrome c from
mitochondria. However, the possibility of a transient depolariza-
tion prior to cytochrome c release without affecting the overall
mitochondrial ∆ Ym and JC-1 labelling cannot be ruled out. 
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A recent study (Goldstein et al, 2000) followed the release of
Green Fluorescent Protein-tagged cytochrome c during apoptosis
in HeLa cells induced by a variety of agents, finding that all of
the cytochrome c is released from all mitochondria within a
given cell in a short constant time period of 5 min, irrespective of
the timing of the onset of release, which depended on the type
and strength of the particular apoptotic stimulus. In that work,
the release of cytochrome c differed from the loss of ∆ Ym in that
only the latter depended on caspase activity. Even though the
release of cytochrome c was accompanied by mitochondrial
depolarization, in the presence of the pan-caspase inhibitor
zVAD-fmk, cytochrome c was released to the cytosol in the
absence of loss of ∆ Ym. To explain their results, the authors
(Goldstein et al, 2000) proposed the formation of holes, tears or
pores in the mitochondrial outer membrane without an alteration
of the inner membrane, which maintains ∆ Ym. Such perforations
in the outer membrane would allow cytochrome c and other
mitochondrial proteins residing in the intermembrane space to
diffuse out of the mitochondria in a relatively temperature-inde-
pendent manner. Such a mechanism may explain certain
responses of mitochondria of LY-R cells treated with Pc 4-PDT.
We have found (Varnes et al, 1999) that the inhibition of respira-
tion that occurs in response to Pc 4-PDT can be largely reversed
by the addition of exogenous cytochrome c to digitonin-perme-
abilized LY-R cells. The results suggest that the respiratory inhi-
bition is due to the loss of cytochrome c from the mitochondria
rather than to extensive damage to the inner membrane and respi-
ratory complexes. Thus, in LY-R cells exposed to lethal, but not
supralethal, doses of Pc 4-PDT, the efflux of cytochrome c may
be triggered by photodamage to the outer mitochondrial
membrane. 
Although the role of cytochrome c in caspase activation is well
documented, little is known concerning the detailed mechanism
for the regulation of caspase activation by cytochrome c. Our data
show that the kinetics of caspase-3-like activation by PDT is dose
dependent with higher doses of PDT inducing faster activation of
the caspase. In spite of these differences in kinetics, no detectable
difference was found in the timing or the extent of cytochrome c
release after the PDT doses studied. These observations suggest
the existence of an additional level of regulation of caspase activa-
tion after cytochrome c release. 
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